logo-loader

Adaptimmune Therapeutics PLC

Market:
NASDAQ
Market Cap:
$505.08 m
Price
3.90 USD
Change
-1.27%
52 weeks high
6.00
52 weeks low
0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.